Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Cardiovascular Research|September 14, 2017
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitabilityGiulia Campostrini, Mattia Bonzanni, Alessio Lissoni, et al.
British Journal of Cancer|August 1, 2021
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trialUgo De Giorgi, Maddalena Sansovini, Stefano Severi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II studyIrene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
The Prostate|August 24, 2019
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastasesOliver Sartor, Daniel Heinrich, Neil Mariados, et al.
Cardiovascular Research|February 4, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytesMarcella Rocchetti, Luca Sala, Lisa Dreizehnter, et al.
Frontiers in Endocrinology|February 6, 2023
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumorsChiara Liverani, Chiara Spadazzi, Toni Ibrahim, et al.
Future Oncology (London, England)|October 11, 2014
Single bone metastasis from adenocarcinoma of the lacrimal gland: a case reportMarianna Ricci, Elena Amadori, Fausto Chiesa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 31, 2025
Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutationAnthony Frosio, Procolo Marchese, Giorgia Bertoli, et al.
Oncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-upStefano Severi, Ilaria Grassi, Alberto Bongiovanni, et al.
Pageof 13